Physician profile
Danny E Sankovic
NPI 1386715753
$1,001.57
in general payments reported to CMS, 2019-2025
10 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $228 · 2020: $276 · 2021: $91.38 · 2022: $266 · 2023: $39.66 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $459.87 | 2019-2023 | Sutab, Suflave |
| Kci USA, INC. | $158.91 | 2019-2022 | |
| Integra Lifesciences Corporation | $97.17 | 2022 | |
| Ethicon US, LLC | $93.34 | 2020 | |
| Solventum Corporation | $81.97 | 2025 | Activ.A.C. |
| Ferring Pharmaceuticals INC. | $39.16 | 2019 | |
| Shionogi INC | $22.16 | 2023 | Fetroja |
| Pacira Pharmaceuticals Incorporated | $18.25 | 2025 | Iovera, Zilretta, Exparel |
| Acacia Pharma INC | $18.07 | 2021 | |
| Microline Surgical INC | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Sankovic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.